🔎 Trials Near Me

Domov › Rakovina prostaty › Kalifornia › Sacramento

Klinické štúdie Rakovina prostaty v meste Sacramento, CA

19 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v meste Sacramento a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Prebieha náborFáza 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Vek 18 a viac · Muži · Aktualizované 2. 10. 2026 · NCT06931340

Distance-Based Exercise to Preserve Function and Prevent Disability

Prebieha nábor
  • Kaiser Permanente-South Sacramento, Sacramento
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07059884

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Prebieha náborFáza 3
  • University of California Davis Comprehensive Cancer Center, Sacramento
Vek 18 a viac · Muži · Aktualizované 2. 10. 2026 · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Prebieha náborFáza 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06632977

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 míľ odtiaľ
Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Prebieha náborFáza 3
  • University of California Davis (UC Davis) Comprehensive Cancer Center ( Site 0114), Sacramento
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06136650

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prebieha náborFáza 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
  • South Sacramento Cancer Center, Sacramento
Vek 18 a viac · Muži · Aktualizované 10. 9. 2026 · NCT05946213

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Prebieha náborFáza 3
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 míľ odtiaľ
Vek 18 a viac · Muži · Aktualizované 19. 8. 2026 · NCT04423211

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Prebieha náborFáza 2
  • University of California Davis, Sacramento
Vek 18 a viac · Muži · Aktualizované 14. 8. 2026 · NCT04812366

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Prebieha náborFáza 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Vek 18 až 100 · Muži · Aktualizované 13. 8. 2026 · NCT05519449

Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies

Prebieha nábor
  • UC Davis Departments of Urologic Oncology, Sacramento
Vek 18 a viac · Muži · Aktualizované 6. 8. 2026 · NCT06907446

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prebieha náborFáza 3
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 míľ odtiaľ
Vek 18 a viac · Muži · Aktualizované 14. 7. 2026 · NCT06592924

Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer

Prebieha nábor
  • University of California Davis Comprehensive Cancer Center, Sacramento
Vek 18 a viac · Muži · Aktualizované 30. 6. 2026 · NCT06178354

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

Prebieha nábor
  • University of California, Davis, Sacramento
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 6. 2026 · NCT06101290

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

Prebieha náborFáza 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Vek 18 a viac · Muži · Aktualizované 14. 4. 2026 · NCT06235697

Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

Prebieha náborFáza 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Vek 18 a viac · Muži · Aktualizované 13. 3. 2026 · NCT06173362

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Prebieha náborFáza 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 2. 2026 · NCT06778863

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Prebieha náborFáza 2
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 míľ odtiaľ
Vek 18 a viac · Muži · Aktualizované 29. 1. 2026 · NCT05806515

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Prebieha náborFáza 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • University of California Davis Comprehensive Cancer Center, Sacramento
  • a 2 ďalších
Vek 18 a viac · Muži · Aktualizované 11. 9. 2025 · NCT03678025

Štúdie Rakovina prostaty v iných mestách

Iné štúdie v Sacramento

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.